Home / People / Ellen Gielen
Portrait of Ellen Gielen

Ellen Gielen


Newtonlaan 203
3584 BH Utrecht
PO Box 85250
3508 AG Utrecht
Languages English, Dutch

Ellen Gielen is head of the Life Sciences group in the Netherlands. She is an expert in regulatory, compliance and complex contractual matters and represents leading international life science companies, like Amgen, Boston Scientific and Johnson & Johnson, on a wide range of pharmaceutical and medical device product issues, including manufacturing & distribution, pricing & reimbursement and advertising, both on domestic and EU level. ​

She is renowned for developing and securing innovative partnership models in the field of "patient support programmes" and "hospital solutions". Ellen is an experienced litigator related to life sciences matters and also teaches a number of pharma law masterclasses at Smelt Academy (a Dutch institute for learning and development in life sciences and health), such as on contracting with hospitals. ​

Ellen also has experience in many areas of healthcare law, in particular relating to contracts, market regulation, partnerships and privatization, medical practice acquisitions, licences, registrations, fees, reimbursements and budgeting and health insurance.

more less

Ellen Gielen’s in-depth knowledge of health laws is complimented by an outstanding knowledge of the medical/health sector

The Legal500 EMEA, 2022

Clients laud her as an "authority on life science-related topics," adding that she is a "fantastic repository of knowledge."

Chambers Europe, 2022

Broad and in-depth experience on pharmaceutical matters and practical approach to legal and business challenges.

Chambers Europe 2021

‘Ellen Gielen is very focused and delivers practical advise moving our business forward. Has a thorough understanding of the health sector.’

The Legal 500 EMEA, 2020

"Has extensive experience of regulatory regimes."

The Legal 500, 2019

Relevant experience

  • Representing a global cardiovascular company which has its global marketing and sales headquarters in the Netherlands. We have drawn up all their commercial agreements such as distribution agreements, agency agreements, sales agreements and their general terms and conditions. Assisting this client with any issues regarding the termination of such agreements.
  • Acting for a global medical device company in the drafting and negotiating of a cooperation agreement with a hospital in the Netherlands. Focus of this partnership is the provision of services to the hospital which are designed to maximise operational efficiency through effective management and modernisation programmes, thus generating sustainable efficiencies to critical operational departments, so-called hospital solutions. It was the first agreement of its kind in the Netherlands and brought a number of challenges with it, on issues like liability, competition law and regulatory guidelines for medical devices.
  • Acted for a global medical device company. We have drawn up their commercial agreements. We also support this client on regulatory matters. 
  • Acting for a global bio-pharmaceutical company. We support them on a large number of agreements, including all their commercial agreements.
  • Advising a USA based medical device company on regulatory issues for medical device clinical trials.
  • Advises on legal classification, import and distribution of human-derived (engineered) tissue products.
  • Advises on setting up a cross-border internet/mail order pharmacy business.
  • Advises on the set-up of so-called health management services in the Netherlands, including drafting all agreements related to the project. Health management services are pharmaceutical company services which enable them to provide added value to patients, health care providers and health insurance funds to improve patient outcomes and reduce the disease-related burden for all stakeholders. 
  • Advises on the set-up of a subsidiary of a global pharmaceutical company in the Netherlands, which involved assisting them with obtaining the necessary licenses, drafting agreements, such as LSP agreements, service agreements etc.
  • Advises a manufacturer on their new distribution structure, setting up the required network, including the drafting of the new distribution agreements. Assists them, including litigation, in the termination of existing contracts with their distributors.
  • Over the last several years, assisting several clients on their new distribution structure.  The above project is the most recent example of our expertise in this area.
more less

Memberships & Roles

  • Complaints Committee of a BOPZ Institution, an institution governed by the Psychiatric Hospitals Compulsory Admission Act
  • Dutch Pharmaceutical Law Association
  • Appeal Committee of the Royal Dutch Hockey Association (KNHB)
more less


  • Dutch Law (Company Law), Erasmus University
  • Business Administration, Erasmus University
more less


CMS has ad­vised CF Group on its ac­quis­i­tion of the Star­line Group
CMS has ad­vised CF Group, an in­ter­na­tion­al Ger­man fam­ily busi­ness, on its ac­quis­i­tion of the Star­line Group. Foun­ded in 1974, Star­line Group is a lead­ing man­u­fac­turer of swim­ming pools and swim­ming pool...
Ad­verse ef­fects of drugs and vac­cines The Neth­er­lands
1. Drug ad­verse ef­fects: kinds of re­spons­ib­il­ity 1.1 Which are the main kinds of re­spons­ib­il­ity (con­trac­tu­al, in tort, crim­in­al) of the fol­low­ing sub­jects with re­spect to ad­verse drugs re­ac­tions? A...
Can­nabis law and le­gis­la­tion in the Neth­er­lands
Med­ic­al use The Dutch Opi­um Act dis­tin­guishes drugs with a low risk of harm (‘soft drugs’) from drugs with a high risk of harm (‘hard drugs’). Can­nabis is lis­ted un­der the soft drugs cat­egory...
Glob­al Life Sci­ences & Health­care Fest­iv­al 2021 - Vir­tu­al
Join us for this year's Glob­al Life Sci­ences & Health­care Fest­iv­al 2021 - Vir­tu­al from 29 Novem­ber to 2 Decem­ber.  Day 1: Ar­ti­fi­cial In­tel­li­gence in Life Sci­ences & Health­care: New busi­ness mod­els in...
Vac­cine com­pens­a­tion re­gimes in the Neth­er­lands
1. Are COV­ID-19 vac­cin­a­tions ob­lig­at­ory in your jur­is­dic­tion? Are you ex­pect­ing any le­gis­lat­ive changes to en­able man­dat­ory vac­cines for all or cer­tain people (e.g. health­care pro­fes­sion­als, pub­lic ser­vants...
Top rank­ings CMS in Leg­al 500 EMEA 2021
CMS has once again been ranked in the latest edi­tion of The Leg­al 500 Europe, Middle East & Africa (2021). We thank our cli­ents for put­ting their trust in us and re­cog­nising our ex­pert­ise. Our law­yers...
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? 1.1 Medi­cines The Medi­cines Act is the primary law on ad­vert­ising of medi­cines. In ad­di­tion, the Dutch Civil Code...
Top rank­ings CMS in Cham­bers Europe 2021
CMS is once again ranked in the latest edi­tion of the Cham­bers Europe guide. A big thanks to our cli­ents for put­ting their trust in us and re­cog­nising our ex­pert­ise.CMS in the Neth­er­lands is ranked in...
Di­git­al health apps and telemedi­cine in the Neth­er­lands
Di­git­al Health Apps/Soft­ware 1. How is the soft­ware with­in di­git­al health apps clas­si­fied in your jur­is­dic­tion, and what reg­u­la­tion(s) ap­ply? The rel­ev­ant le­gis­la­tion is the “Wet op de medis­che hulp­mid­delen...
Pod­cast: Ad­vert­ising of Medi­cines and Med­ic­al Devices
The series brings to­geth­er CMS law­yers and ex­perts to dis­cuss key in­dustry top­ics im­pact­ing, in­nov­at­ing and dis­rupt­ing the life sci­ences & health­care sec­tor.  In Epis­ode #2, Nick Beck­ett (China/Hong...
AI in Life Sci­ences
Ar­ti­fi­cial in­tel­li­gence is not new: the term it­self was coined over 60 years ago. However, the con­ver­gence of data volume, pro­cessing power and tech­nic­al cap­ab­il­ity has con­vinced many that the AI era...
Top rank­ings CMS in Leg­al 500 EMEA 2020
The on­line edi­tion of The Leg­al 500 Europe, Middle East & Africa (EMEA) 2020 has been pub­lished. Our law­yers are de­scribed as 'ac­cur­ate, quick, flex­ible and know­ledge­able'. CMS is val­ued for its pres­ence...